0001657312-16-000001.txt : 20160720 0001657312-16-000001.hdr.sgml : 20160720 20160720145701 ACCESSION NUMBER: 0001657312-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160720 DATE AS OF CHANGE: 20160720 EFFECTIVENESS DATE: 20160720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-267396 FILM NUMBER: 161775231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE D 1 primary_doc.xml X0707 D LIVE 0001657312 Verona Pharma plc 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2RE 011-44-0-2032834200 UNITED KINGDOM None None Corporation true Jan-Anders Karlsson C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2RE Executive Officer Director Kenneth Newman C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2RE Executive Officer Peter Spargo C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2RE Executive Officer David Ebsworth C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2RE Director Ken Cunningham C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2RE Director Patrick Humphrey C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2RE Director Anders Ullman C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 UNITED KINGDOM SE1 2RE Director Pharmaceuticals Decline to Disclose 06b false 2016-06-17 false true true false 420995 MTS SECURITIES, LLC 104059 None None 623 FIFTH AVENUE 14TH FLOOR NEW YORK NY NEW YORK 10022 CA CALIFORNIA MD MARYLAND MA MASSACHUSETTS NY NEW YORK false 44524058 44524058 0 Based on exchange rate GBP 1.00 to USD 1.324889. false 8 2892788 true 0 0 false Verona Pharma plc Jan-Anders Karlsson Jan-Anders Karlsson Chief Executive Officer 2016-07-20